Skip to content
DeepViews

Establishment Labs Holdings Inc. (ESTA) — Analysis Summary

Establishment Labs Holdings Inc. (ESTA) has a market cap of $1.84B with year-over-year revenue growth of +27.1%. Net margin stands at -24.2%. The stock trades at a P/E ratio of -47.2.

Key Takeaways

  • Revenue changed +27.1% year-over-year
  • Net margin of -24.2%
  • P/E ratio of -47.2

Compared to other companies in the ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES sector, ESTA posted revenue growth of +27.1% and trades at a P/E of -47.2.

[XNAS]

Establishment Labs Holdings Inc. (ESTA)

$61.63

PREVIOUS CLOSE 2026-10-12 · MARKET DATA POLYGON · FINANCIALS SEC EDGAR

Market Cap
$1836.69M
Enterprise Value
$2027.24M
P/E Ratio
-47.2
Div Yield
0.00%
EV/EBITDA
N/A
Company Profile
About
About Establishment Labs Holdings Inc.

Establishment Labs Holdings Inc is a medical technology company engaged in offering medical devices and aesthetic products. It is involved in the designing, manufacturing, and marketing of silicone-filled breast and body-shaping implants. The company markets its products under Motiva implants Brand. It distributes its products to medical distributors; and physicians, hospitals, and clinics in the form of direct sales. Its geographical segments are Europe, Latin America, Asia-Pacific/Middle East, and Others.

Sector

ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES

Employees

1,004

Headquarters

ALAJUELA, G2

Exchange

XNAS

Website
Source: Polygon.io
Score
Competitive Moat
Competitive Moat
48
Narrow Moat

Systematic competitive advantage assessment based on 4yr data

This assessment is based on quantitative analysis of historical financial data and does not constitute investment advice. Moat ratings may change with industry and competitive dynamics.

Market Signals
Valuation
Earnings
Insider Activity
Insider Filing Activity

First version surfaces recent SEC Forms 3, 4, and 5 activity. It does not yet parse individual buy/sell transactions.

Loading SEC insider filing activity...
Superinvestors
Financial Health
Financial Health

Capital Structure

Total Equity$21.61M
Total Debt$261.70M
Debt-to-Equity12.11
Cash & Equivalents$71.16M

Cash Flow

Operating Cash Flow$-32.32M
Free Cash Flow$-41.51M
FCF Margin-16.89%
P/FCF Ratio-44.25
Source: Polygon.io · SEC EDGAR
Dividends
Recent News
Recent News

Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.